Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma


Study Number
1706021
Phase
I/II
Age Group
Adult
Pediatric
Purpose

The purpose of this study is to evaluate the safety and efficacy of nivolumab, or nivolumab in combination with azacitidine in participants with recurrent, resectable osteosarcoma

Full Title

MCC 19487 A Phase Ib/II Study to Evaluate the Safety, Feasibility and Efficacy of Nivolumab or Nivolumab in Combination with Azacitidine in Patients with Recurrent, Resectable Osteosarcoma

ClinicalTrials.Gov ID
NCT03628209

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.